Ganjoo, Kristen N.
Stanford Cancer Institute · Stanford University
2 papers on CoChatORCID 0000-0003-0452-9967
Most cited papers
- Verified
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., et al. (2019) · Journal of Clinical Oncology
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 268
- Verified
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
Chawla, S. P., Cranmer, L. D., Van Tine, B. A., Reed, D. R., Okuno, S. H., Butrynski, J. E., Adkins, D. R., Hendifar, A. E., Kroll, S., & Ganjoo, K. N. (2014) · Journal of Clinical Oncology
Sarcoma Diagnosis and TreatmentBioactive Compounds and Antitumor Agents
Cited by 155
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free